Al Jazeera
http://www.aljazeera.com/Services/Search/?q=vaccine
Accessed 9 August 2014
Experts: Give new US Ebola drug to Africans
World’s top Ebola specialists question why only US aid workers given experimental drug, but firm says little available

The Atlantic
http://www.theatlantic.com/magazine/
Accessed 9 August 2014
An Ebola Vaccine Is Not the Answer
Instead, we need a treatment and better quarantine measures.
Olga Khazan
5 August 2014
In a widely shared Onion article from a few days ago, scientists “announced” that an Ebola vaccine was still 50 white people away. This was a jab at pharmaceutical companies, who, cynics think, will only set their R&D wheels in motion if there’s money on the horizon….

Council on Foreign Relations
http://www.cfr.org/
Accessed 9 August 2014
Transcript : The Ebola Outbreak
with John Campbell, Laurie Garrett, Robert McMahon August 5, 2014
CFR fellows discuss the recent Ebola outbreak in western Africa and its effect on the region.

Forbes
http://www.forbes.com/
Accessed 9 August 2014
BioWar Lab Helping To Develop Treatment For Ebola
Paul Rodgers, Contributor Aug 04, 2014
A top U.S. biological-warfare unit is developing a treatment for the deadly Ebola virus and could have it in the field within two years. The virus, which has killed more than 800 people in West Africa as of August 4, is a “Category A Bioterrorism Agent” along with anthrax, botulism, bubonic…

The Guardian
http://www.guardiannews.com/
Accessed 9 August 2014
Ebola rages in Africa as west agonises over ethics of vaccine and drug testing
31 July 2014
In 2002, scientists writing in a leading American medical journal discussed the possibility that the Ebola virus could be used in a biochemical weapon. It would be technically difficult and unlikely to cause mass destruction because those infected quickly die and the virus is not as transmissible as many assume. But, the scientists warned, if it could be done, there would be no protection. No vaccine or drug treatment exists…

New Yorker
http://www.newyorker.com/
Accessed 9 August 2014
After Ebola – The New Yorker
Jul 31, 2014 … There are several vaccines under development; in early animal tests, more than one has shown promise. But it will be years before they are …

New York Times
http://www.nytimes.com/
Accessed 9 August 2014
Ebola Drug Could Save a Few Lives. But Whose?
By ANDREW POLLACK AUG. 8, 2014
With hundreds of Africans dying from the outbreak of Ebola, some activists have said it is wrong that extremely scarce supplies of an experimental drug went to two white American aid workers.
But others wonder: What if the first doses of the drug — which had never been used in people and had not even finished the typical animal safety testing — had been given to African patients instead?
“It would have been the front-page screaming headline: ‘Africans used as guinea pigs for American drug company’s medicine,’ ” said Dr. Salim S. Abdool Karim, director of Caprisa, an AIDS research center in South Africa.
A history of controversy about drug testing in Africa is just one of the complexities facing public health authorities as they wrestle with whether and how to bring that drug and possibly other experimental ones to the countries afflicted with Ebola. Who should get such a scarce supply of medicine? Health workers? Children? The newly infected who are not yet as sick?
There are virtually no remaining supplies of the drug, called ZMapp, that was used to treat the two Americans, United States officials say. And even a few months from now, according to various estimates, there may be no more than a few hundred doses….
Inside Hospital’s Ebola Battle
August 9, 2014
At the government hospital in Kenema, Sierra Leone, health care workers struggle to contain the Ebola epidemic, which has killed almost 1,000 people across West Africa.